Catalyst, in collaboration with the Emily Whitehead Foundation, publishes Amplifying the Voice of CAR T-Cell Therapy Patients and Caregivers

December 16, 2024

Understanding the patient experience with CAR-T long-term follow-up (LTFU) is essential for building a sustainable model. Catalyst Healthcare Consulting, in partnership with the Emily Whitehead Foundation, surveyed nearly 100 patients and caregivers to capture their perspectives.

The findings are outlined in the whitepaper Amplifying the Voice of CAR T-Cell Therapy Patients and Caregivers, which highlights the urgent need for patient-centered LTFU processes — an increasingly critical focus as more CAR T-cell therapies receive FDA approval and reach a growing number of patients

Thank you! Your submission has been received!

Download file

Oops! Something went wrong while submitting the form.

Recent News

NEW WHITE PAPER: Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (Preprint)

Multistakeholder collaboration, led by Catalyst Healthcare Consulting, to Recommend Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (preprint).

Cell & Gene Therapy is making swift progress, and Catalyst is keeping pace

Scientific innovation in Cell & Gene Therapy (C&GT) is advancing rapidly, sparking hope for patients with rare diseases, cancer, and other debilitating conditions

Recent blogs

Nancy Myers Speaks on Better Leveraging Existing Knowledge During OTP Public Listening Meeting

Catalyst CEO, Nancy Myers, had the opportunity to address CBER leadership during OTP’s September 18th public listening meeting titled “Leveraging Knowledge for Facilitating the Development and Review of Cell and Gene Therapies.” Though a PDUFA VII commitment and a required action, meetings like this one provide a critical space for industry and the Agency to share ideas and deliver better outcomes for patients.

Plan for Consolidating FDA’s Adverse Event Reporting Systems: Good Idea but Easier Said than Done

NEW WHITE PAPER: Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (Preprint)

Multistakeholder collaboration, led by Catalyst Healthcare Consulting, to Recommend Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (preprint).

Catalyst, in collaboration with the Emily Whitehead Foundation, publishes Amplifying the Voice of CAR T-Cell Therapy Patients and Caregivers

December 16, 2024

Recent News

NEW WHITE PAPER: Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (Preprint)

Cell & Gene Therapy is making swift progress, and Catalyst is keeping pace

Recent blogs

Nancy Myers Speaks on Better Leveraging Existing Knowledge During OTP Public Listening Meeting

Plan for Consolidating FDA’s Adverse Event Reporting Systems: Good Idea but Easier Said than Done

NEW WHITE PAPER: Data-Informed Optimization of CAR T-Cell Therapy Long-Term Follow-Up (Preprint)

Sitemap

Newsletter